...or in-licensing deals since the start of 2016, and acquired three companies: Ariad Pharmaceuticals Inc., TiGenix N.V....
...partner press releases, company interviews Partner Technology Deal terms Financial terms Partnership date Cell therapy TiGenix N.V....
...cell therapy Cx601 to treat complex perianal fistulas in Crohn’s disease. In 2018, Takeda acquired TiGenix...

...$96.0 $105.0 -9% Stem cells Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) Gained in acquisition of TiGenix N.V....

...Madrid, Spain) hired Virginia Gonzalez as CFO. She was head of consolidation and reporting at TiGenix N.V....

...Therachon AG (Basel, Switzerland) hired Claudia D'Augusta as its first CFO. D'Augusta was CFO at TiGenix N.V....

...as CMO. She succeeds Jean-Louis Abitbol, who will retire in April. Richard was CMO at TiGenix N.V....

...Nanovector ASA (OSE:NANO) hired Eduardo Bravo as CEO, effective July 2. He was CEO at TiGenix N.V....

...succeeded by Roger Connor, president of GSK's global manufacturing and supply unit, effective September 1. TiGenix N.V....
...Sebastian Wehle and TiGenix CFO Claudia D’Augusta will be in charge of daily management of TiGenix...

...and now approved to treat ALK-positive non-small cell lung cancer (NSCLC). The proposed acquisition of TiGenix N.V....
...Servier, Suresnes, France Shire plc (NASDAQ:SHPG), Dublin, Ireland Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan TiGenix N.V....

...heavily treatment-experienced patients with HIV-1 whose infections cannot be treated successfully with existing multidrug-resistant therapies TiGenix N.V....

...Celgene Corp. (NASDAQ:CELG) Impact Biomedicines Inc. 1/8/18 $1,100.0 $5,900.0 $7,000.0 Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) TiGenix N.V....